TERT promoter mutations in thyroid cancer

TERT promoter mutations (TERT-p mutations) have been found in many types of cancer and have emerged to play critical roles in tumor progression. The mutations upregulate TERT transcription, and TERT not only elongates telomeres and confers unlimited proliferative capacity on tumor cells, but is also...

Full description

Saved in:
Bibliographic Details
Main Authors: Michiko Matsuse, Norisato Mitsutake
Format: Article
Language:English
Published: The Japan Endocrine Society 2023-11-01
Series:Endocrine Journal
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0136/_html/-char/en
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591691628937216
author Michiko Matsuse
Norisato Mitsutake
author_facet Michiko Matsuse
Norisato Mitsutake
author_sort Michiko Matsuse
collection DOAJ
description TERT promoter mutations (TERT-p mutations) have been found in many types of cancer and have emerged to play critical roles in tumor progression. The mutations upregulate TERT transcription, and TERT not only elongates telomeres and confers unlimited proliferative capacity on tumor cells, but is also involved in tumor progression and aggressiveness. In differentiated thyroid carcinoma, TERT-p mutations are associated with a number of high-risk clinicopathological aggressiveness and worse prognosis, making it the best molecular marker to predict tumor aggressiveness so far. This review summarizes recent relevant findings regarding TERT-p mutations and their functional/mechanistic aspects.
format Article
id doaj-art-3d1d60a7c28941d19f207257e6d5fdbd
institution Kabale University
issn 1348-4540
language English
publishDate 2023-11-01
publisher The Japan Endocrine Society
record_format Article
series Endocrine Journal
spelling doaj-art-3d1d60a7c28941d19f207257e6d5fdbd2025-01-22T06:23:18ZengThe Japan Endocrine SocietyEndocrine Journal1348-45402023-11-0170111035104910.1507/endocrj.EJ23-0136endocrjTERT promoter mutations in thyroid cancerMichiko Matsuse0Norisato Mitsutake1Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, JapanDepartment of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, JapanTERT promoter mutations (TERT-p mutations) have been found in many types of cancer and have emerged to play critical roles in tumor progression. The mutations upregulate TERT transcription, and TERT not only elongates telomeres and confers unlimited proliferative capacity on tumor cells, but is also involved in tumor progression and aggressiveness. In differentiated thyroid carcinoma, TERT-p mutations are associated with a number of high-risk clinicopathological aggressiveness and worse prognosis, making it the best molecular marker to predict tumor aggressiveness so far. This review summarizes recent relevant findings regarding TERT-p mutations and their functional/mechanistic aspects.https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0136/_html/-char/enthyroid cancertelomerase reverse transcriptase (tert)promotermutation
spellingShingle Michiko Matsuse
Norisato Mitsutake
TERT promoter mutations in thyroid cancer
Endocrine Journal
thyroid cancer
telomerase reverse transcriptase (tert)
promoter
mutation
title TERT promoter mutations in thyroid cancer
title_full TERT promoter mutations in thyroid cancer
title_fullStr TERT promoter mutations in thyroid cancer
title_full_unstemmed TERT promoter mutations in thyroid cancer
title_short TERT promoter mutations in thyroid cancer
title_sort tert promoter mutations in thyroid cancer
topic thyroid cancer
telomerase reverse transcriptase (tert)
promoter
mutation
url https://www.jstage.jst.go.jp/article/endocrj/70/11/70_EJ23-0136/_html/-char/en
work_keys_str_mv AT michikomatsuse tertpromotermutationsinthyroidcancer
AT norisatomitsutake tertpromotermutationsinthyroidcancer